(Q33415693)

English

Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation (English)

1 reference

Europe PubMed Central

26 July 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

thrombotic thrombocytopenic purpura

1 reference

based on heuristic

inferred from title

Marcelo Addas-Carvalho

object named as

Marcelo Addas-Carvalho

9

0 references

Fernanda Andrade Orsi

object named as

Fernanda Andrade Orsi

3

0 references

Erich V De Paula

object named as

Erich Vinícius De Paula

2

0 references

author name string

Bianca Stefanello

1

1 reference

Europe PubMed Central

26 July 2017

Jose Francisco Comenalli Marques

4

1 reference

Europe PubMed Central

26 July 2017

Eduardo Gasparotto Roveri

5

1 reference

Europe PubMed Central

26 July 2017

Marina Pereira Colella

6

1 reference

Europe PubMed Central

26 July 2017

Margareth Castro Ozelo

7

1 reference

Europe PubMed Central

26 July 2017

Joyce Maria Annichino-Bizzacchi

8

1 reference

Europe PubMed Central

26 July 2017

publication date

3 June 2014

1 reference

Europe PubMed Central

26 July 2017

Journal of Clinical Apheresis

1 reference

Europe PubMed Central

26 July 2017

29

1 reference

Europe PubMed Central

26 July 2017

6

1 reference

Europe PubMed Central

26 July 2017

311-315

1 reference

Europe PubMed Central

26 July 2017

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

A novel association of acquired ADAMTS13 inhibitor and acute dengue virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

THROMBOTIC THROMBOCYTOPENIC PURPURA

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Design of the prospective randomized study for the treatment of patients with thrombotic microangiopathy. PRODROMI Study Group

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Thrombotic thrombocytopenic purpura--then and now.

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Thrombotic thrombocytopenic purpura: recognition and management

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1002%2FJCA.21336

21 January 2018

Identifiers

10.1002/JCA.21336

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33415693&oldid=1953398639"